Jason E Farley1, Laura E Starbird2, Jill Anderson2, Nancy A Perrin3, Kelly Lowensen2, Tracy Ross4, Karen C Carroll4. 1. Department of Community and Public Health, Johns Hopkins University School of Nursing, Baltimore, MD. Electronic address: jfarley1@jhu.edu. 2. Department of Community and Public Health, Johns Hopkins University School of Nursing, Baltimore, MD. 3. Johns Hopkins Center for Global Health, Johns Hopkins University School of Nursing, Baltimore, MD. 4. Division of Medical Microbiology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD.
Abstract
BACKGROUND:People living with HIV (PLWH) have a higher prevalence of methicillin-resistant Staphylococcus aureus (MRSA) colonization and likelihood of recurrent infection than the general population. Simultaneously treating MRSA-colonized household members may improve success with MRSA decolonization strategies. This article describes a pilot trial testing household-level MRSA decolonization and documents methodologic and pragmatic challenges of this approach. METHODS: We conducted a randomized controlled trial of individual versus individual-plus-household MRSA decolonization to reduce recurrent MRSA. PLWH with a history of MRSA who are patients of an urban HIV clinic received a standard MRSA decolonization regimen. MRSA colonization at 6 months was the primary outcome. RESULTS:One hundred sixty-six patients were referred for MRSA screening; 77 (46%) enrolled. Of those, 28 (36%) were colonized with MRSA and identified risk factors consistent with the published literature. Eighteen were randomized and 13 households completed the study. CONCLUSIONS: This is the first study to report on a household-level MRSA decolonization among PLWH. Challenges included provider referral, HIV stigma, confidentiality concerns over enrolling households, and dynamic living situations. Although simultaneous household MRSA decolonization may reduce recolonization, recruitment and retention challenges specific to PLWH limit the ability to conduct household-level research. Efforts to minimize these barriers are needed to inform evidence-based practice.
RCT Entities:
BACKGROUND:People living with HIV (PLWH) have a higher prevalence of methicillin-resistant Staphylococcus aureus (MRSA) colonization and likelihood of recurrent infection than the general population. Simultaneously treating MRSA-colonized household members may improve success with MRSA decolonization strategies. This article describes a pilot trial testing household-level MRSA decolonization and documents methodologic and pragmatic challenges of this approach. METHODS: We conducted a randomized controlled trial of individual versus individual-plus-household MRSA decolonization to reduce recurrent MRSA. PLWH with a history of MRSA who are patients of an urban HIV clinic received a standard MRSA decolonization regimen. MRSA colonization at 6 months was the primary outcome. RESULTS: One hundred sixty-six patients were referred for MRSA screening; 77 (46%) enrolled. Of those, 28 (36%) were colonized with MRSA and identified risk factors consistent with the published literature. Eighteen were randomized and 13 households completed the study. CONCLUSIONS: This is the first study to report on a household-level MRSA decolonization among PLWH. Challenges included provider referral, HIV stigma, confidentiality concerns over enrolling households, and dynamic living situations. Although simultaneous household MRSA decolonization may reduce recolonization, recruitment and retention challenges specific to PLWH limit the ability to conduct household-level research. Efforts to minimize these barriers are needed to inform evidence-based practice.
Authors: Marcela Rodriguez; Patrick G Hogan; Melissa Krauss; David K Warren; Stephanie A Fritz Journal: J Pediatric Infect Dis Soc Date: 2013-02-11 Impact factor: 3.164
Authors: Valerie C Cluzet; Jeffrey S Gerber; Irving Nachamkin; Joshua P Metlay; Theoklis E Zaoutis; Meghan F Davis; Kathleen G Julian; David Royer; Darren R Linkin; Susan E Coffin; David J Margolis; Judd E Hollander; Rakesh D Mistry; Laurence J Gavin; Pam Tolomeo; Jacqueleen A Wise; Mary K Wheeler; Warren B Bilker; Xiaoyan Han; Baofeng Hu; Neil O Fishman; Ebbing Lautenbach Journal: Clin Infect Dis Date: 2015-02-03 Impact factor: 9.079
Authors: Wil Ng; Amna Faheem; Allison McGeer; Andrew E Simor; Antonella Gelosia; Barbara M Willey; Christine Watt; David C Richardson; Henry Wong; Krystyna Ostrowska; Lee Vernich; Matthew P Muller; Piraveina Gnanasuntharam; Vanessa Porter; Kevin Katz Journal: Infect Control Hosp Epidemiol Date: 2016-11-08 Impact factor: 3.254
Authors: Jason E Farley; Matthew J Hayat; Paul L Sacamano; Tracy Ross; Karen Carroll Journal: Am J Infect Control Date: 2015-02-14 Impact factor: 2.918
Authors: Kyle J Popovich; Bala Hota; Alla Aroutcheva; Lisa Kurien; Janki Patel; Rosie Lyles-Banks; Amanda E Grasso; Andrej Spec; Kathleen G Beavis; Mary K Hayden; Robert A Weinstein Journal: Clin Infect Dis Date: 2013-01-16 Impact factor: 9.079
Authors: Md Tauqeer Alam; Timothy D Read; Robert A Petit; Susan Boyle-Vavra; Loren G Miller; Samantha J Eells; Robert S Daum; Michael Z David Journal: mBio Date: 2015-03-10 Impact factor: 7.867
Authors: Philip J Peters; John T Brooks; Sigrid K McAllister; Brandi Limbago; H Ken Lowery; Gregory Fosheim; Jodie L Guest; Rachel J Gorwitz; Monique Bethea; Jeffrey Hageman; Rondeen Mindley; Linda K McDougal; David Rimland Journal: Emerg Infect Dis Date: 2013-04 Impact factor: 6.883